Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - Biostage, Inc. | tm205241d1_ex32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - Biostage, Inc. | tm205241d1_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Biostage, Inc. | tm205241d1_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Biostage, Inc. | tm205241d1_ex31-1.htm |
| EX-21.1 - EXHIBIT 21.1 - Biostage, Inc. | tm205241d1_ex21-1.htm |
| EX-4.9 - EXHIBIT 4.9 - Biostage, Inc. | tm205241d1_ex4-9.htm |
| 10-K - FORM 10-K - Biostage, Inc. | tm205241d1_10k.htm |
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Biostage, Inc.:
We consent to the incorporation by reference in the Registration Statements on Form S-1 (No. 333-215410), and Forms S-8 (No. 333-192026, 333-192027, 333-203105, 333-212993, 333-219988, 333-225336) of Biostage, Inc. of our report dated March 27, 2020, relating to the consolidated financial statements of Biostage, Inc. and subsidiaries, appearing in this Annual Report on Form 10-K of Biostage, Inc. for the year ended December 31, 2019.
| /s/ RSM US LLP | |
| Boston, Massachusetts | |
| March 27, 2020 |